Pf761 reduced intensity conditioning regimen with alemtuzumab based t cell depletion enables early post-transplantation cellular intervention restoring graft versus leukemia effects in older aml patients
HemaSphere（2019）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要